Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Hypertrophic cardiomyopathy (HCM) is caused by point mutations in sarcomeric proteins. Here the authors develop an optimized model of the sequestered state of cardiac myosin and define the features affecting the lever arm compliance, allowing them to group mutations in classes and to elucidate the m...
Guardado en:
Autores principales: | Julien Robert-Paganin, Daniel Auguin, Anne Houdusse |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e873de0aea84aacbc93a135a9252b29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
por: Arjun S. Adhikari, et al.
Publicado: (2019) -
Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil
por: Vicente J. Planelles-Herrero, et al.
Publicado: (2017) -
Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014) -
Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021) -
Plasmodium myosin A drives parasite invasion by an atypical force generating mechanism
por: Julien Robert-Paganin, et al.
Publicado: (2019)